Drug Shortage Report for CEREBYX

Last updated on 2023-04-01 History
Report ID 176939
Drug Identification Number 02230988
Brand name CEREBYX
Common or Proper name Cerebyx
Company Name SEARCHLIGHT PHARMA INC
Market Status MARKETED
Active Ingredient(s) FOSPHENYTOIN SODIUM
Strength(s) 75MG
Dosage form(s) SOLUTION LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5x2ml
ATC code N03AB
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-12-01
Actual start date 2022-12-01
Estimated end date 2023-03-31
Actual end date 2023-03-31
Shortage status Resolved
Updated date 2023-04-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1600 RUE NOTRE DAME OUEST, SUITE 312
MONTREAL, QUEBEC
CANADA H3J 1M1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-12-02 English Compare
v2 2022-12-02 French Compare
v3 2023-01-13 English Compare
v4 2023-01-13 French Compare
v5 2023-02-17 English Compare
v6 2023-02-17 French Compare
v7 2023-03-06 English Compare
v8 2023-03-06 French Compare
v9 2023-03-20 English Compare
v10 2023-03-20 French Compare
v11 2023-04-01 English Compare
v12 2023-04-01 French Compare

Showing 1 to 12 of 12